← Eichor
Study identifier: NCT06006559 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Condition: Dengue  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 2
Planned participants108
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

The purpose of this study is to characterize the effect on dengue viral load, fever clearance time as well as on clinical signs and symptoms with the treatment of EYU688 compared with placebo in patients with dengue fever.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  +41613241111  ·  novartis.email@novartis.com

Novartis Pharmaceuticals

Always discuss trial participation with your own doctor first.

Locations (24)

Novartis Investigative SiteManaus, Amazonas, BrazilRecruiting
Novartis Investigative SiteBrasília, Federal District, BrazilRecruiting
Novartis Investigative SiteRio de Janeiro, Rio de Janeiro, BrazilRecruiting
Novartis Investigative SiteRio Grande, Rio Grande do Sul, BrazilRecruiting
Novartis Investigative SiteSorocaba, São Paulo, BrazilRecruiting
Novartis Investigative SiteSao Jose Rio Preto, BrazilRecruiting
Novartis Investigative SiteBarranquilla, Atlántico, ColombiaWithdrawn
Novartis Investigative SiteBucaramanga, Santander Department, ColombiaWithdrawn
Novartis Investigative SiteCali, Valle del Cauca Department, ColombiaRecruiting
Novartis Investigative SiteBelagavi, Karnataka, IndiaRecruiting
Novartis Investigative SiteMumbai, Maharashtra, IndiaWithdrawn
Novartis Investigative SitePune, Maharashtra, IndiaRecruiting

+ 12 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06006559